塔卡亚苏动脉炎中的炎:基于病例的文献综述
Xin Dang1, Qingqing Zhu2, Yuzhen Zou1
1Department of Rheumatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
International journal of rheumatic diseases
|June 4, 2023
概括
塔卡亚苏动脉炎 (TAK) 是一种大血管血管炎,可伴有炎或静脉炎症. 这项研究表明,炎可能是活跃TAK的被忽视的指标,可能发生在9.1%的病例中.
科学领域:
- 类风湿病学 类风湿病学
- 血管医学 血管医学
- 内部医学 内部医学
背景情况:
- 塔卡亚苏动脉炎 (TAK) 主要影响大动脉,如大动脉.
- 静脉参与TAK并不常见,但可以表现为炎.
- 早期诊断和了解TAK表现对于患者的治疗结果至关重要.
研究的目的:
- 报告一个塔卡亚苏动脉炎的病例,呈现出疹.
- 调查TAK.中炎和疾病活动之间的关联.
- 为了估计TAK患者的炎发病率.
主要方法:
- 一个被诊断患有TAK的27岁女性的案例介绍.
- 诊断标准:1990年美国风湿病学学院TAK标准.
- 血管超声波以评估静脉壁的厚度 (马卡罗尼标志).
- 对患者数据的回顾性分析,以估计炎发病率.
- 关于TAK表现的文献综述.
主要成果:
- 患者出现肌痛和夜间出汗,诊断为TAK.
- 超声波显示了多个静脉中的静脉壁加厚 (马卡罗尼标志).
- 与活动疾病相关的TAK相关的炎,并在缓解后消失.
- 在回顾性研究中,TAK患者中风的估计发病率为9.1%.
结论:
- 炎可能是高山氏动脉炎的不寻常但显著的表现.
- 炎似乎与TAK疾病活动密切相关.
- 炎可能是活跃TAK中未被认可的症状,需要进一步调查.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
13
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13
Atherosclerosis IV: Nursing Management
27
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
27
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
19
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
19
Peripheral Artery Disease I: Introduction
11
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
16
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
16


